Research Comparison

Sermorelin vs Tesamorelin

Sermorelin and Tesamorelin are often compared because both sit in growth-hormone axis research. Sermorelin acts on GHRH receptor (GHRHR) and is studied for pituitary GH-secretion research, while Tesamorelin acts on GHRH analog and is studied for visceral/hepatic fat research. Both are supplied as lyophilized powder for in-vitro laboratory research only — this page compares mechanism and research status, not dosing or human use.

Sermorelin

Growth-hormone axis

Tesamorelin

Growth-hormone axis

Category
Growth-hormone axis
Growth-hormone axis
Mechanism / target
GHRH receptor (GHRHR)
GHRH analog
Research status
Research-use-only (former Geref diagnostic)
Approved formulations exist
Studied for
Pituitary GH-secretion research
Visceral/hepatic fat research
Form
Lyophilized powder
Lyophilized powder

Sermorelin

Pituitary GH-secretion research.

Tesamorelin

Visceral/hepatic fat research.

Frequently asked

What is the difference between Sermorelin and Tesamorelin?
The main difference is mechanism and research stage. Sermorelin targets GHRH receptor (GHRHR) (research-use-only (former geref diagnostic)) and is studied for pituitary GH-secretion research; Tesamorelin targets GHRH analog (approved formulations exist) and is studied for visceral/hepatic fat research. Both are research-use-only compounds, not for human or animal use.
Are Sermorelin and Tesamorelin approved for human use?
No. Renova Wellness supplies both strictly for in-vitro laboratory and scientific research use only. Research status differs — Sermorelin: research-use-only (former geref diagnostic); Tesamorelin: approved formulations exist — but neither is sold for human or animal consumption, and no medical, therapeutic, or dosing claims are made.
How is purity verified for Sermorelin and Tesamorelin?
Every lot of both compounds ships with its own per-batch Certificate of Analysis — identity by mass spectrometry, ≥98% purity by HPLC, and a unique lot number you can verify against the vial in your hand.

Related comparisons

Build a multi-compound set in the Stack Builder or run the reconstitution calculator.

Research references

Primary literature for Sermorelin and Tesamorelin. Provided for scientific context only — not medical or dosing guidance.

  1. Falutz J, et al. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation. J Acquir Immune Defic Syndr. 2010. PMID 20101189
  2. Stanley TL, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation. JAMA. 2014. PMID 25038357

Research use only. This comparison covers mechanism, target, and research status. It is not medical, therapeutic, or dosing advice. Compounds sold by Renova Wellness™ are for in-vitro laboratory research and are not for human or animal consumption.